Recent advances in the study of FAT family genes in lung cancer.

Discov Oncol · 2025 · PMC12540217 · PMID 41117853

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

likely to be significantno p-value reported

Mutations in FAT1 are likely to be significant biomarkers in NSCLC, identifying groups of patients who do not respond well to ICIs and providing important scientific evidence for the development of personalized and precise immunotherapeutic regimens [ 81 ].

also in 492 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.